The Australasian Leukaemia & Lymphoma Group (ALLG) is Australia and New Zealand’s only not-for-profit blood cancer clinical trial research group.
Driven by our purpose ‘Better treatments…Better lives’, the ALLG is committed to improving the treatment, lives and survival rates of patients with blood cancers through clinical trial conduct. Working collaboratively with blood cancer specialists locally and internationally, our impact is profound.
Important ALLG Downloads
ALLG 50th Anniversary Commemorative Booklet
Our 50th Anniversary commemorative booklet highlights our research journey aimed at improving blood cancer patient outcomes. Learn how ALLG and our Members have supported patients and healthcare providers over last five decades.
ALLG Annual Research Report
The ALLG annual Research Report publication for calendar year 2022 includes summaries and detailed information on the current ALLG clinical trial program. In particular, we thank our Scientific Advisory Committee and Scientific Working Party Chairs and committee members for their dedication in progressing ALLG clinical trials, for patients to have better treatments.
ALLG Annual Review
ALLG had a positive financial year. This success is due to our strong partnerships and collaborations. In particular, we thank our members and patients and look forward to more trials creating better treatments and better lives.
Our membership includes more than 1000 blood cancer specialists who are united by a common goal to find better ways to treat blood cancers through clinical trial conduct.
Help make a difference to the life of someone who has blood cancer. For patients and their loved ones, your donation means an improved chance of cure and better quality of life.
Gain access to cutting-edge, potentially life-saving new treatments before they’re widely available to the public. Many people with cancer are now living longer, with a better quality of life, due to clinical trials.